Evidence map›Paper›PMID 35579936›Full record

ArticleStem cells and development2022

Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling.

Katie M Hamel, Connor T King, Maryn B Cavalier, Kara Q Liimatta, Grace L Rozanski, Timothy A King, Meggie Lam, Grace C Bingham, C Ethan Byrne, Diensn Xing and 6 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Stem cells and development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Katie M HamelDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Connor T KingDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Maryn B CavalierDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Kara Q LiimattaDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Grace L RozanskiDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Timothy A KingDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Meggie LamDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Grace C BinghamDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
C Ethan ByrneDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Diensn XingDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Bridgette M Collins-BurowSection of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Matthew E BurowSection of Hematology and Medical Oncology, Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
Jorge A BelgodereDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Melyssa R BrattonCollege of Pharmacy, Xavier University, New Orleans, Louisiana, USA.
Bruce A BunnellDepartment of Microbiology, Immunology and Genetics, University of North Texas Health Sciences Center, Fort Worth, Texas, USA.ORCID 0000-0001-6196-3722
Elizabeth C MartinDepartment of Biological Engineering, Louisiana State University, Baton Rouge, Louisiana, USA.
Louisiana State University · USTulane University · USUniversity of North Texas · USXavier University of Louisiana · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Xavier RCMI Renewal Application-Research Infrastructure CoreU54MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI Guangdi Wang, Christopher Williams · 2019 to 2026
$41.9M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Adipose tissue is characterized as an endocrine organ that acts as a source of hormones and paracrine factors. In diseases such as cancer, endocrine and paracrine signals from adipose tissue contribute to cancer progression. Young individuals with estrogen receptor-alpha positive (ER-α

Indexed as

Breast NeoplasmsAdipose TissueAdultAgedCell ProliferationCulture Media, ConditionedEstrogensFemaleHumansInterferon-gammaInterleukin-10Interleukin-2Interleukin-6PPAR gammaReceptors, EstrogenRNA, MessengerCulture Media, ConditionedEstrogensInterferon-gammaInterleukin-10Interleukin-2Interleukin-6PPAR gammaReceptors, EstrogenRNA, MessengerTumor Necrosis Factor-alphaadipose-derived stromal/stem cellsbreast cancerendocrine responseparacrine signaling

Identifiers

PMID35579936
PMCPMC9595652
OpenAlexW4280558594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.